| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $349.9M | +24.9% |
| Cost of Revenue | $77.0M | +23.7% |
| Gross Profit | $272.8M | +25.3% |
| R&D Expense | $134.6M | +11.0% |
| SG&A Expense | $63.1M | +13.6% |
| Operating Income | -$75.5M | +15.9% |
| Pre-tax Income | -$54.5M | +35.7% |
| Income Tax | $6.7M | +23.9% |
| Net Income | -$61.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.8M | +85.9% |
| Short-term Investments | $460.2M | +15.8% |
| Accounts Receivable | $76.4M | +23.1% |
| Current Assets | $645.8M | +21.4% |
| Total Assets | $972.6M | +11.6% |
| Current Liabilities | $262.2M | +25.1% |
| Total Liabilities | $293.4M | +19.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.2M | +246.1% |
| Capital Expenditures | $2.0M | -54.2% |
| Investing Cash Flow | -$53.5M | -0.3% |
| Financing Cash Flow | $18.4M | +66.6% |
| Free Cash Flow | $72.2M | +322.1% |
| +32.1% |
| EPS (Basic) | -$0.59 | +35.2% |
| EPS (Diluted) | -$0.59 | +35.2% |
| Stockholders' Equity |
| $679.1M |
| +8.7% |